5AM Partners VII LLC 13D and 13G filings for Skye Bioscience, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-08-18 7:57 pm Sale | 2026-08-14 | 13D | SKYE BIOSCIENCE INC SKYE | 5AM Partners VII LLC | 1,409,176 30.200% | -33,489 (-2.32%) | Filing |
| 2025-12-16 4:30 pm Sale | 2025-12-12 | 13D | SKYE BIOSCIENCE INC SKYE | 5AM Partners VII LLC | 1,442,665 34.000% | -19,447 (-1.33%) | Filing |
| 2024-12-19 6:09 pm Sale | 2024-12-17 | 13D | SKYE BIOSCIENCE INC SKYE | 5AM Partners VII LLC | 1,462,112 36.400% | -25,896 (-1.74%) | Filing |
| 2024-03-13 7:28 pm Purchase | 2024-03-13 | 13D | SKYE BIOSCIENCE INC SKYE | 5AM Partners VII LLC | 1,488,008 40.000% | 57,187 (+4.00%) | Filing |
| 2024-01-31 4:15 pm Purchase | 2024-01-29 | 13D | SKYE BIOSCIENCE INC SKYE | 5AM Partners VII LLC | 1,430,821 44.200% | 652,218 (+83.77%) | Filing |